Newborn Screening for Hemoglobin Disorders

REFERENCES

• Newborn screening for sickle cell disease and other hemoglobinopathies. National Institutes of Health Consensus Development Conference Statement. 1987;1–8.
   Google Scholar
• Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005;116(6):818–825.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. The Thalassemias. In: Stamatoyannopoulos G, Ed. The Molecular Basis of Blood Diseases, 2nd ed. Philadelphia: W.B. Saunders Company. 1994:157–160.
   Google Scholar
• Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P. Clinical manifestation of β-thalassemia/Hemoglobin E disease. J Pediatr Hematol Oncol. 2000;22(6):552–557.
   PubMed Web of Science ®Google Scholar
• Singer ST, Kuypers FA, Olivieri NF, . E/β Thalassaemia Study Group. Fetal haemoglobin augmentation in E/β0 thalassaemia: clinical and haematological outcome. Br J Haematol. 2005;131(3):378–388.
   PubMed Web of Science ®Google Scholar
• Aessopos A, Kati M, Farmakis D. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology. Haematologica. 2007;92(5):658–665.
   PubMed Web of Science ®Google Scholar
• Li DZ, Liao C. A case of transfusion-dependent nondeletional Hb H disease undiagnosed during prenatal screening for thalassemia. Prenat Diagn. 2008;28(2):165–166.
   PubMed Web of Science ®Google Scholar
• Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004:14–34.
   Google Scholar
• U.S. Department of Commerce Minority Business Development Agency. Dynamic Diversity: Projected Changes in U.S. Race and Ethnic Composition 1995 to 2050. U.S. Census Report. 1999.
   Google Scholar
• Gaston MH, Verter JL, Woods W, . for the Prophylactic Penicillin Study Group. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314(25):1593–1599.
   PubMed Web of Science ®Google Scholar
• State of California, Department of Finance. Population Projections for California and Its Counties 2000–2050. 2007; Sacramento, California.
   Google Scholar
• Michlitsch J, Azimi M, Hoppe C, . Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009;52(4):486–490.
   PubMed Web of Science ®Google Scholar
• Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol. 1996;13(5):501–512.
   PubMed Web of Science ®Google Scholar
• Hoppe CC. Newborn screening for non-sickling hemoglobinopathies. Hematology Am Soc Hematol Educ Program. 2009:19–25.
   Google Scholar
• Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California’s newborn screening program (see comments). J Pediatr Hematol Oncol. 1996;18(1):36–41.
   PubMed Web of Science ®Google Scholar
• Githens JH, Lane PA, McCurdy RS, Houston ML, McKinna JD, Cole DM. Newborn screening for hemoglobinopathies in Colorado: the first 10 years. Am J Dis Child. 1990;144(4):466–470.
   PubMedGoogle Scholar
• Dumars KW, Boehm C, Eckman JR, Giardina PJV, Lane PA, Shafer FE. Practical guide to the diagnosis of thalassemia. Council of Regional Networks for Genetic Services (CORN). Am J Med Genet. 1996;62(1):29–37.
   PubMed Web of Science ®Google Scholar
• Lane PA, Eckman JR. Cost-effectiveness of neonatal screening for sickle cell disease. J Pediatr. 1992;120(1):162–163.
   PubMed Web of Science ®Google Scholar
• Lorey F. Asian immigration and public health in California: thalassemia in newborns in California. J Pediatr Hematol Oncol. 2000;22(6):564–566.
   PubMed Web of Science ®Google Scholar
• National Newborn Screening and Genetics Resource Center. National Newborn Screening Report – 1998. NNSGRC, Austin, TX, December 2001.
   Google Scholar
• Hoppe C, Azimi M, Aslanian S, Lubin B, Vichinsky E, Therrell B. An effective program to resolve ambiguous results from state newborn hemoglobinopathy screening. Blood. 2004;104(11):969a.
   PubMed Web of Science ®Google Scholar
• Eastman JW, Wong R, Liao CL, Morales DR. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem. 1996;42(5):704–710.
   PubMed Web of Science ®Google Scholar
• Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem. 2004;50(10):1736–1747.
   PubMed Web of Science ®Google Scholar
• Lorey F, Cunningham G, Vichinsky EP, . Universal newborn screening for Hb H disease in California. Genet Test. 2001;5(2):93–100.
   PubMedGoogle Scholar
• Feuchtbaum L, Dowray S, Lorey F. The context and approach for the California newborn screening short- and long-term follow-up data system: preliminary findings. Genet Med. 2010;12(12, Suppl):S242–S250.
   Web of Science ®Google Scholar
• Lorey F, Cunningham G, Shafer F, Lubin B, Vichinsky E. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens. Eur J Hum Genet. 1994;2(4):262–271.
   PubMedGoogle Scholar
• Kidd JL, Azimi M, Lubin B, Vichinsky E, Hoppe C. Application of an expanded multiplex genotyping assay for the simultaneous detection of Hemoglobin Constant Spring and common deletional α-thalassemia mutations. Int J Lab Hematol. 2010;32(4):373–380.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol. 1991;28(3):220–226.
   PubMed Web of Science ®Google Scholar
• Kidd J, Witkowska E, Lubin B, Vichinsky E, Chui DHK, Trachtenberg E. α Thalassemia mutations detected by multiplex PCR. Blood. 1999;94(10):196a.
   Web of Science ®Google Scholar
• Redon R, Carter NP. Comparative genomic hybridization: microarray design and data interpretation. Methods Mol Biol. 2009;529:37–49.
   PubMedGoogle Scholar